Breaking News Instant updates and real-time market news.

DERM

Dermira

$10.06

-0.27 (-2.61%)

16:04
08/06/18
08/06
16:04
08/06/18
16:04

Dermira reports Q2 EPS (57c), consensus (51c)

Reports Q2 revenue $39.1M, consensus $39.2M. "We closed the second quarter with an historic milestone for Dermira - the FDA approval of QBREXZA," said Tom Wiggans, chairman and CEO of Dermira. "I'm excited about what the second half of the year holds for us as we continue our efforts to launch QBREXZA and the opportunity to bring relief to the millions suffering from primary axillary hyperhidrosis, a medical condition that results in sweating beyond what is needed for normal body temperature regulation."

  • 07

    Aug

DERM Dermira
$10.06

-0.27 (-2.61%)

03/06/18
GUGG
03/06/18
DOWNGRADE
GUGG
Neutral
Dermira downgraded to Neutral from Buy at Guggenheim
03/06/18
NEED
03/06/18
NO CHANGE
Target $19
NEED
Buy
Dermira price target lowered to $19 from $43 at Needham
Needham analyst Serge Belanger lowered his price target on Dermira to $19 from $43 after the company's failed DRM01 acne program due to "surprising and disappointing failures across the phase 3 CLAREOS trials". Belanger states that the focus now shifts to Dermira's other assets such as hyperhidrosis which has a PDUFA at the end of June and lebrikizumab which is currently in a phase 2 study with expected readout in mid-2019. The analyst keeps his Buy rating, noting that the sell-off following the DRM01 announcement does not take into account Dermira's remaining asset values.
05/25/18
CANT
05/25/18
NO CHANGE
Target $20
CANT
Overweight
Dermira 23% selloff not based on fundamentals, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen says she sees no fundamental reason for the 23% decline yesterday in shares of Dermira. The analyst day underscored the opportunities for glycopyrronium tosylate in excessive sweating and Lebrikizumab in atopic dermatitis, Chen tells investors in a research note. She believes glycopyrronium tosylate approval should drive the stock higher and keeps an Overweight rating on the name with a $20 price target. Chen notes that investors she spoke with were concerned that consensus numbers need to come down.
05/25/18
NEED
05/25/18
NO CHANGE
Target $16
NEED
Buy
Dermira price target lowered to $16 from $19 at Needham
Needham analyst Serge Belanger lowered his price target on Dermira to $16 after the company's inaugural analyst day which focused on the commercial launch strategy for DRM04 to reflect the higher than anticipated launch costs for the program. The analyst keeps his Buy rating however, saying his expectations for FDA approval of DRM04 are high given the "solid" phase 3 data, forecasting the treatment to have a significant role in the hyperhidrosis market which currently has few effective alternatives. Belanger adds that the stock price "undervalues DRM04's potential and largely ignores the lebrikizumab program".

TODAY'S FREE FLY STORIES

CUK

Carnival plc

$52.15

-3.54 (-6.36%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
Carnival plc falls -6.2% »

Carnival plc is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

DWT

Britannia Bulk

$6.68

-0.46 (-6.44%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
Britannia Bulk falls -6.5% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$41.58

-3.26 (-7.27%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -7.3% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$26.39

1.91 (7.80%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
California Resources rises 7.2% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Apr

BBBY

Bed Bath & Beyond

$17.82

3.95 (28.48%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Options
Active trading in Bed, Bath and Beyond options as shares rally »

Active trading in Bed,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

KEG

Key Energy

$4.48

0.59 (15.17%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
Key Energy rises 15.7% »

Key Energy is up 15.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

IO

ION Geophysical

$13.84

0.25 (1.84%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
ION Geophysical rises 7.7% »

ION Geophysical is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$137.77

1.13 (0.83%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Hot Stocks
Janssen submits sBLA for daratumumab combination therapy to FDA »

Janssen Pharmaceutical of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 25

    Apr

WAB

Wabtec

$70.62

0.62 (0.89%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Options
Wabtec put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$17.74

3.87 (27.90%)

, DO

Diamond Offshore

$10.69

0.39 (3.79%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Options
Early notable gainers among liquid option names on March 26th »

Notable gainers among…

BBBY

Bed Bath & Beyond

$17.74

3.87 (27.90%)

DO

Diamond Offshore

$10.69

0.39 (3.79%)

VIAB

Viacom

$27.08

0.75 (2.85%)

RIG

Transocean

$9.27

0.44 (4.98%)

NVDA

Nvidia

$181.50

7.695 (4.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

  • 22

    May

DWDP

DowDuPont

$53.96

0.7 (1.31%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Conference/Events
House Science, Space & Technology to hold a hearing »

The Subcommittee on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 28

    May

09:51
03/26/19
03/26
09:51
03/26/19
09:51
Conference/Events
House Financial Services Committee to hold a markup »

The Committee holds a…

09:50
03/26/19
03/26
09:50
03/26/19
09:50
General news
U.S. Richmond Fed index preview: »

U.S. Richmond Fed index…

SQ

Square

$74.65

0.12 (0.16%)

09:49
03/26/19
03/26
09:49
03/26/19
09:49
Recommendations
Square analyst commentary  »

Opposition to Square ILC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,199.98

7.26 (0.61%)

, GOOGL

Alphabet Class A

$1,204.92

7.79 (0.65%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Periodicals
Google's Local Experiments Project looks to bolster community news, Axios says »

Google (GOOG, GOOGL) is…

GOOG

Alphabet

$1,199.98

7.26 (0.61%)

GOOGL

Alphabet Class A

$1,204.92

7.79 (0.65%)

MNI

McClatchy

$5.01

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$41.92

-2.92 (-6.51%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -6.5% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$6.70

-0.44 (-6.16%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Britannia Bulk falls -6.4% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUK

Carnival plc

$51.67

-4.02 (-7.22%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Carnival plc falls -6.6% »

Carnival plc is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

BBW

Build-A-Bear

$5.86

0.22 (3.90%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Build-A-Bear rises 4.1% »

Build-A-Bear is up 4.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCO

Universal Compression

$21.55

0.86 (4.16%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Universal Compression rises 4.2% »

Universal Compression is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$25.64

1.16 (4.74%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
California Resources rises 4.6% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Apr

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
U.S. consumer confidence preview: »

U.S. consumer confidence…

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
Consumer Confidence to be reported at 10:00 »

March Consumer Confidence…

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

March Richmond Fed…

MDSO

Medidata

$75.89

(0.00%)

09:44
03/26/19
03/26
09:44
03/26/19
09:44
Hot Stocks
Breaking Hot Stocks news story on Medidata »

Medidata mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.